Track topics on Twitter Track topics that are important to you
In vitro diagnostics IVD is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 20142020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography North America, Europe, Asia Pacific and Rest of World. Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020.nnIncrease in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market. Widespread knowledge of healthcare amp; its benefits, and cost effectiveness are some top impacting factors of the global IVD market. The stringent regulatory policies and reimbursement issues are limiting the growth of the market. Furthermore, the rising demand for technologically advanced diagnosis devices and increased spending capabilities of consumers on health care provides huge potential for IVD in Asia Pacific market.nbsp;nnIVD Techniques Market AnalysisnnGlobal IVD techniques market is been segmented based on immunoassays, clinical chemistry, point of care, molecular diagnostics, hematology, coagulation, microbiology and other clinical techniques. Point of care is the highest revenuegenerating segment in the overall IVD techniques market. Molecular diagnostics is the fastest growing technique in the in the overall IVD techniques market due to its ability to detect the primary cause of the disease accuratelynnIVD Product Type Market AnalysisnnThe product type segment is been segmented based on instruments, reagents, data management systems and services. Instruments hold the highest market share in the global IVD market followed by reagents. Reagents market is also growing at a faster pace. As it is mostly used in various equipment and play a key role in the overall diagnosis process. Rise in the usage of diagnostic devices in which reagents are required for performing diagnosis tests, is the major factor that drives the product type market.nbsp;nnIVD Usability Market AnalysisnnUsability segment is classified as disposable and reusable IVD devices. Doctors and clinicians currently prefer disposable devices, to avoid infections. Still, reusable IVD device holds the largest revenue share in the global IVD usability market. Cost effectiveness as a benefit of reusable devices is driving the growth of usability market.nnIVD Applications Market AnalysisnnThe application area is segmented based on infectious diseases, diabetes, cancer/oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious diseases generated the highest revenue for current and forecast period mainly due to rise in the incidences of infectious diseases. HIV/AIDS application market is the second largest revenue generating applications segment and would remain the second largest through 2020.nnIVD End User Market AnalysisnnHospitals, laboratories, academics, point of care testing and others are the end users of global IVD market. Academic institutions provide trainings of IVD to the students. Laboratories generate the highest revenue followed by point of care for global end user market. Rise in the number of laboratories in Asia Pacific regions and increased awareness about health care and its benefits are contributing towards the growth of laboratories market, which in turn drives the global IVD end users market.nnIVD Geography Market AnalysisnnThe detailed analysis of the global IVD market is done in various regions such as North America, Europe, Asia Pacific and Rest of World. North America is the largest revenue generating region in all segments of global IVD market, whereas Asia Pacific region is fastest growing region amongst the regions studied.nnIVD Competitive AnalysisnnThe study of top ten players in the global market reveals strategies adopted to maintain their position in the competitive market. Strategic analysis of the top players reveals that market players are adopting product launch as their key developmental strategy in the market, as the market players are innovating novel products to expand their product line. Acquisitions and approvals are some additional strategies adopted by the companies in the market to enhance their services and expand their reach across the globe.nnIVD High Level AnalysisnnThe market exploration provides a clear view of global IVD market. Porterrsquo;s fiveforce model helps in analyzing market players, new entrants in the market and the novel strategies adopted by them. In the current business scenario, IVD market has moderate bargaining power of supplier due to existence of brand loyalty. Varying product differentiation would lead to moderate buyersrsquo; bargaining. High entry barriers lead to lower threat of new entrants. Intersegment substitution leads to lower threat of Substitute. The value chain analysis reveals the key intermediaries involved in the supply chain. Raw material suppliers, medical device manufacturers, distributors, service providers and end users are the various stakeholders involved in the supply chain of IVD market.nnReason For StudynnIVD is the oldest technique for diagnosis of the disease. With increase in incidences of chronic and infectious diseases and rise in healthcare awareness amongst patients, the market is opportunistic in different geographies. As there is a shift from traditional diagnostic devices to advanced diagnostic devices, IVD would prove to be a lucrative market in future.nnKEY DELIVERABLESnnnnAssessments are made according to the current business scenario and the future market trends are forecast for the period 20132020, with the base figures of the year 2013nnThe analysis gives a wider view of the global market including its market trends, market structure, limiting factors and opportunities for the marketnnPorterrsquo;s five forcersquo;s model helps in analyzing the potential of buyers amp; suppliers, and the competitive sketch of the market, which would guide the market players to develop strategies accordinglynnThe value chain analysis provides a systematic study on the key intermediaries involved, which would in turn help the stakeholders in the market to make appropriate strategiesnnThe advantages of the market are analyzed to help the stakeholders identify the opportunistic areas in a comprehensive mannernnnKEY MARKET SEGMENTSnnMARKET BY TECHNIQUESnnnnImmunoassaysnnClinical ChemistrynnPoint Of CarennMolecular DiagnosticsnnHematologynnCoagulationnnMicrobiologynnOther clinical techniquesnnnMARKET BY PRODUCT TYPEnbsp;nnnnInstrumentsnnReagentsnnData management systemsnnServicesnnnMARKET BY USABILITYnnnnDisposablennReusablenbsp;nnnMARKET BY APPLICATIONSnnnnInfectious DiseasesnnDiabetesnnCancer/OncologynnCardiologynnAutoimmune DiseasesnnNephrologynnDrug TestingnnHIV/AIDSnnOthersnnnMARKET BY END USERnnnnHospitalsnnLaboratoriesnnAcademicsnnPoint of Care TestingnnOthersnnnMARKET BY GEOGRAPHYnnnnNorth AmericannEuropennAsia PacificnnRest of WorldnNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...